{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:52:16Z","timestamp":1781643136692,"version":"3.54.5"},"reference-count":22,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Clin Cancer Inform"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Immune-related colitis (IR-colitis) is a significant side effect of immune checkpoint inhibitor (ICI) therapy for an expanding group of cancers. Timely identification is required to optimize outcomes, but existing approaches to retrospective case detection are resource intensive. We sought to develop an electronic medical record (EMR)-based digital phenotype to identify patients with IR-colitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Adult patients commenced on ICIs from August 1, 2020, to June 30, 2023, at the Peter MacCallum Cancer Centre were studied. ICIs were prescribed as monotherapy or in combination with other treatment modalities for a variety of solid cancers. Deidentified EMR data were extracted. A rule-based digital phenotype was developed using expert-selected features, with manual chart review serving as the gold standard comparator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The ICI-treated cohort comprised 1,464 adults, with a male predominance (62%). The most frequent cancer diagnoses were melanoma (28.5%) and non\u2013small cell lung cancer (20.5%). Administered ICIs included nivolumab (41.4%) and ipilimumab (23.2%). On manual chart review, 147 (10.0%), 1,287 (87.9%), and 30 (2%) patients were defined as IR-colitis cases, controls, and equivocal cases, respectively. For the best-performing rule-based digital phenotype, sensitivity was 0.80 (95% CI, 0.73 to 0.86), specificity was 0.97 (95% CI, 0.96 to 0.98), positive predictive value was 0.74 (95% CI, 0.66 to 0.80), negative predictive value was 0.98 (95% CI, 0.97 to 0.98), accuracy was 0.89 (95% CI, 0.85 to 0.92), positive likelihood ratio (LR) was 24.6 (95% CI, 18.08 to 33.47), and negative LR was 0.2 (95% CI, 0.15 to 0.28). The F1 score was 0.77.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>We successfully developed an accurate digital phenotype for IR-colitis using real-world EMR data. It allows rapid and accurate cohort identification, which may be adapted to support retrospective immune-related adverse event surveillance and translational biomarker research in the real world.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/cci-25-00366","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:00:17Z","timestamp":1781640017000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Digital Phenotype for Immune-Related Colitis"],"prefix":"10.1200","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-8673","authenticated-orcid":true,"given":"Jasmine C.","family":"Teng","sequence":"first","affiliation":[{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Worth","sequence":"additional","affiliation":[{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.","family":"Thursky","sequence":"additional","affiliation":[{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Centre for Health Services Research in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Trinh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Spain","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia"},{"name":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9716-9133","authenticated-orcid":true,"given":"Phillip K.","family":"Tran","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9204-3216","authenticated-orcid":true,"given":"Tim","family":"Spelman","sequence":"additional","affiliation":[{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Centre for Health Services Research in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chowa","family":"Nkonde","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Terreros-Martin","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-2344","authenticated-orcid":true,"given":"George","family":"Roubos","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-5532","authenticated-orcid":true,"given":"Dimiter","family":"Shinkov","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-1256","authenticated-orcid":true,"given":"Daniel","family":"Capurro","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia"},{"name":"Department of General Medicine, Royal Melbourne Hospital, Parkville, Australia"},{"name":"School of Computing and Information Systems, University of Melbourne, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx286"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000585"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2391"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw539"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002896"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00597-8"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2024.01.004"},{"key":"e_1_3_5_10_2","unstructured":"Centers for Medicare & Medicaid Services: ICD-10. 2025. https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-000896"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2013-002428"},{"key":"e_1_3_5_13_2","volume-title":"The Learning Healthcare System: Workshop Summary","author":"Mc McGinnis JM","year":"2007","unstructured":"Mc McGinnis JM, Aisner D, Olsen L (eds): The Learning Healthcare System: Workshop Summary. Washington, DC, National Academies Press, 2007. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK53494\/"},{"key":"e_1_3_5_14_2","volume-title":"Annual Report 2022-2023","author":"Peter MacCallum Cancer Centre","year":"2023","unstructured":"Peter MacCallum Cancer Centre: Annual Report 2022-2023. Melbourne, Australia, Peter MacCallum Cancer Centre, 2023. https:\/\/www.petermac.org\/document\/files\/peter-mac-annual-report-2023"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102536"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","unstructured":"Feldman TC Kaplan DE Lin A et al: Phenotyping hepatic immune-related adverse events in the setting of immune checkpoint inhibitor therapy. JCO Clin Cancer Inform 10.1200\/CCI.23.00159","DOI":"10.1200\/CCI.23.00159"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1331959"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","unstructured":"Barman H Venkateswaran S Santo AD et al: Identification and characterization of immune checkpoint inhibitor-induced toxicities from electronic health records using natural language processing. JCO Clin Cancer Inform 10.1200\/CCI.23.00151","DOI":"10.1200\/CCI.23.00151"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","unstructured":"Gupta S Belouali A Shah NJ et al: Automated identification of patients with immune-related adverse events from clinical notes using word embedding and machine learning. JCO Clin Cancer Inform 10.1200\/CCI.20.00109","DOI":"10.1200\/CCI.20.00109"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02887-1"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01602-5"}],"container-title":["JCO Clinical Cancer Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/CCI-25-00366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:00:19Z","timestamp":1781640019000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/CCI-25-00366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1200\/CCI-25-00366"],"URL":"https:\/\/doi.org\/10.1200\/cci-25-00366","relation":{},"ISSN":["2473-4276"],"issn-type":[{"value":"2473-4276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500366"}}